MedTrace Logo

Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 Diabetes

NCT00604396 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 477

Last updated 2017-01-27

No results posted yet for this study

Summary

This trial is conducted in Europe.

The aim of this trial is to investigate the safety and efficacy of insulin detemir combined with oral anti-diabetic drugs (OADs) versus insulin NPH combined with oral anti-diabetic drugs (OADs) in Type 2 mellitus not well controlled on current therapy on blood glucose control.

Conditions

Interventions

DRUG

insulin detemir

DRUG

insulin NPH

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-03-31
Primary Completion
2004-01-31
Completion
2004-01-31

Countries

  • Belgium
  • Croatia
  • Denmark
  • France
  • North Macedonia
  • Norway
  • Poland
  • Russia
  • Slovakia
  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00604396 on ClinicalTrials.gov